Urethral cancer overview: Difference between revisions

Jump to navigation Jump to search
No edit summary
 
(5 intermediate revisions by 2 users not shown)
Line 4: Line 4:


== Overview ==
== Overview ==
'''Urethral cancer''' is a rare type of [[cancer]] originating from the [[urethra]]. The [[incidence]] is approximately 0.43 per 100,000 in the united states for [[men]], and approximately 0.15 per 100,000 for [[Women's Health Initiative|women]]. Types of [[urethral]] [[cancer]] include [[transitional cell carcinoma]], [[squamous cell carcinoma]], and [[adenocarcinoma]]. It may be caused by an infection of [[human papillomavirus]]. Urethra cancer must be differentiated from [[bladder cancer]], [[cervical cancer]], [[bladder stones]], ureteral stones, [[cystitis]], [[neurogenic bladder]], and [[urethritis]]. Common [[risk factors]] in the development of urethral cancer are history of [[bladder cancer]], [[urinary tract infections]], and [[sexually transmitted diseases]]. [[Symptoms]] of [[urethral]] [[cancer]] include [[hematuria]], [[urinary hesitancy]], [[frequent urination]], [[incontinence]],  [[swelling]] in the [[groin]], and a lump or thickness in the [[perineum]] or [[penis]]. The [[prognosis]] varies with the depth of invasion, [[anatomical]] location, size, and stage of the [[tumor]]. The predominant [[therapy]] for [[urethral cancer]] is [[surgical]] [[resection]]. Adjunctive [[chemotherapy]] or [[radiation therapy]] may be required.
'''Urethral cancer''' is a rare type of [[cancer]] originating from the [[urethra]]. The [[incidence]] is approximately 0.43 per 100,000 in the [[United states preventive services task force recommendations scheme|United states]] for [[men]], and approximately 0.15 per 100,000 for [[Women's Health Initiative|women]]. Types of [[urethral]] [[cancer]] include [[transitional cell carcinoma]], [[squamous cell carcinoma]], and [[adenocarcinoma]]. It may be caused by an [[infection]] of [[human papillomavirus]]. Urethra cancer must be differentiated from [[bladder cancer]], [[cervical cancer]], [[bladder stones]], urethral stones, [[cystitis]], [[neurogenic bladder]], and [[urethritis]]. Common [[risk factors]] in the development of urethral cancer are history of [[bladder cancer]], [[urinary tract infections]], and [[sexually transmitted diseases]]. [[Symptoms]] of [[urethral]] [[cancer]] include [[hematuria]], [[urinary hesitancy]], [[frequent urination]], [[incontinence]],  [[swelling]] in the [[groin]], and a lump or thickness in the [[perineum]] or [[penis]]. The [[prognosis]] varies with the depth of invasion, [[anatomical]] location, size, and stage of the [[tumor]]. The predominant [[therapy]] for [[urethral cancer]] is [[surgical]] [[resection]]. Adjunctive [[chemotherapy]] or [[radiation therapy]] may be required.


==Classification==
==Classification==
[[Urethral cancer]] may be classified according to cell types into 3 subtypes: [[transitional cell]], [[squamous cell]], and [[adenocarcinoma]]. It may also be classified into distal urethral cancer, proximal urethral cancer and [[urethral cancer]] associated with invasive [[bladder cancer]].
[[Urethral cancer]] may be classified according to cell types into 3 subtypes: [[transitional cell]], [[squamous cell]], and [[adenocarcinoma]]. It may also be classified into distal [[urethral cancer]], proximal urethral cancer and [[urethral cancer]] associated with invasive [[bladder cancer]].


==Causes==
==Causes==
Line 13: Line 13:


==Differential diagnosis==
==Differential diagnosis==
Urethral cancer must be differentiated from [[bladder cancer]], [[cervical cancer]], [[bladder stones]], ureteral stones, [[cystitis]], [[neurogenic bladder]], and [[urethritis]].
[[Urethral cancer]] must be differentiated from [[bladder cancer]], [[cervical cancer]], [[bladder stones]], ureteral stones, [[cystitis]], [[neurogenic bladder]], and [[urethritis]].


==Epidemiology and Demographics==  
==Epidemiology and Demographics==  
[[Urethral]] [[cancer]] is a rare disease that tends to affect African American individuals. The incidence is approximately 0.43 per 100,000 in the united states for men, and approximately 0.15 per 100,000 for women.
[[Urethral]] [[cancer]] is a rare disease that tends to affect African American individuals. The incidence is approximately 0.43 per 100,000 in the [[United states preventive services task force recommendations scheme|United states]] for [[men]], and approximately 0.15 per 100,000 for [[Women's College Hospital|women]].


==Risk Factors==
==Risk Factors==
Common [[risk factors]] in the development of urethral cancer are history of [[bladder cancer]], [[urinary tract infections]], and [[sexually transmitted diseases]].
Common [[risk factors]] in the development of [[urethral cancer]] are history of [[bladder cancer]], [[urinary tract infections]], and [[sexually transmitted diseases]].


==Prognosis==
==Prognosis==
The prognosis varies with the depth of invasion, anatomical location, size, and stage of the [[tumor]]. Superficial tumors located in the distal [[urethra]] have the most favorable [[prognosis]].
The [[prognosis]] varies with the depth of [[invasion]], [[anatomical]] location, size, and stage of the [[tumor]]. Superficial [[tumors]] located in the distal [[urethra]] have the most favorable [[prognosis]].


==Staging==
== Diagnosis ==
The staging of urethral cancer is based on the [[TNM]] staging system.


==History and Symptoms==
===Staging===
Symptoms of urethral cancer include [[hematuria]], [[urinary hesitancy]], [[frequent urination]], [[incontinence]],  [[swelling]] in the groin, and a lump or thickness in the perineum or penis.
The [[Staging (pathology)|staging]] of [[urethral cancer]] is based on the [[TNM]] staging system.


==Physical Examination==
=== Diagnostic study of choice ===
Common physical examination findings of urethral cancer include [[hematuria]], [[urethral discharge]], [[perineal]]/perigenital [[edema]] or [[mass]].
There is no single [[diagnostic]] [[Study arms|study]] of choice for [[Diagnosing Heart Failure in the Emergency Department|diagnosing]] [[urethral]] [[cancer]]. Cystourethroscopy is useful to evaluate the extent of the [[disease]][[Definitive Surgical Trauma Skills|Definitive]] [[diagnosis]] is made with [[Transurethral needle ablation of the prostate|transurethral]] [[biopsies]].


==Laboratory Findings==
===History and Symptoms===
Laboratory findings consistent with the diagnosis of urethral cancer include abnormal cells in urine cytology and [[hematuria]].
[[Symptoms]] of [[urethral cancer]] include [[hematuria]], [[urinary hesitancy]], [[frequent urination]], [[incontinence]],  [[swelling]] in the [[groin]], and a [[lump]] or thickness in the [[perineum]] or [[penis]].


==Other Diagnostic Studies==
===Physical Examination===
Other diagnostic studies for urethral cancer include [[ureteroscopy]] and [[biopsy]].
[[Common- and special-causes|Common]] [[Physical culture|physical]] [[examination]] [[Findings on urinalysis|findings]] of [[urethral cancer]] include [[hematuria]], [[urethral discharge]], [[perineal]]/perigenital [[edema]] or [[mass]].


==Medical Therapy==
===Laboratory Findings===
The predominant therapy for urethral cancer is surgical resection. Adjunctive [[chemotherapy]] or [[radiation therapy]] may be required. The optimal therapy depends on the stage at diagnosis and the anatomic location of the tumor.
[[Laboratory]] [[Findings on urinalysis|findings]] consistent with the [[diagnosis]] of [[urethral]] cancer include abnormal cells in urine cytology and [[hematuria]].


==Surgery==
=== Electrocardiogram ===
Surgery is the mainstay of treatment for urethral cancer. However, it is not recommended among patients with metastatic urethral cancer.
There are no [[electrocardiogram]] [[Findings on urinalysis|findings]] associated with [[urethral]] [[cancer]].


==References==
=== X-ray ===
{{reflist|2}}
There are no [[x-ray]] [[Findings on urinalysis|findings]] associated with [[urethral]] [[cancer]].
 
=== Ultrasound ===
There are no [[echocardiography]]/[[ultrasound]] [[Findings on urinalysis|findings]] associated with [[urethral]] [[cancer]].
 
=== CT scan ===
[[Abdomen]] and [[pelvis]] [[CT angiography|CT]] scan may be helpful in the [[diagnosis]] of [[urethral]] [[cancer]]. [[Findings on urinalysis|Findings]] on [[CT angiography|CT]] scan include extravesical extension to [[lymph nodes]], the [[liver]] or other structures around the [[bladder]], nodal involvement in the [[pelvis]]<nowiki/>or [[retroperitoneum]], [[visceral]], [[pulmonary]], or osseous [[metastasis]].
 
=== MRI ===
[[Abdominal]] and [[pelvic]] [[MRI]] may be helpful in the [[diagnosis]] of [[urethral]] [[cancer]]. [[MRI]] may be superior to [[CT scan]] to detect [[superficial]] and [[Multiple-complex Developmental Disorder|multiple]] [[tumors]], extraurethral [[tumor]] extension, and surrounding organ invasion.
 
=== Other Imaging Findings ===
[[Cystoscopy]] may be helpful for [[Initial-stress-derived noun|initial]] [[diagnosis]] and [[Staging (pathology)|staging]] of [[urethral]] [[cancer]]. Findings of [[cystoscopy]] include Multiple [[biopsy]] specimens from various locations and gross extravesical extension, invasion of adjacent [[organs]], or [[pelvic]] sidewall involvement.
 
===Other Diagnostic Studies===
Other diagnostic studies for [[urethral cancer]] include [[ureteroscopy]] and [[biopsy]].
 
== Treatment ==
 
===Medical Therapy===
The predominant [[therapy]] for [[urethral cancer]] is surgical resection. Adjunctive [[chemotherapy]] or [[radiation therapy]] may be required. The [[Optimal classification|optimal]] [[therapy]] depends on the stage at [[diagnosis]] and the [[anatomic]] location of the [[tumor]].
 
===Surgery===
[[Surgery]] is the mainstay of [[Treatment-resistant depression|treatment]] for [[urethral]] [[cancer]]. However, it is not recommended among [[patients]] with [[metastatic]] [[urethral]] [[cancer]].
 
=== Primary prevention ===
There are no [[Primary & secondary sacroiliac joint disorders|primary]] [[Preventive care|preventive]] measures available for [[urethral]] [[cancer]].
 
=== Secondary prevention ===
There are no established measures for the [[secondary]] [[prevention]] of [[urethral]] [[cancer]].{{reflist|2}}


[[Category:Disease]]
[[Category:Disease]]

Latest revision as of 16:20, 22 January 2019

Urethral cancer Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Urethral cancer from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT Scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Urethral cancer overview On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Urethral cancer overview

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Urethral cancer overview

CDC on Urethral cancer overview

Urethral cancer overview in the news

Blogs on Urethral cancer overview

Directions to Hospitals Treating Urethral cancer

Risk calculators and risk factors for Urethral cancer overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Vindhya BellamKonda, M.B.B.S [2]

Overview

Urethral cancer is a rare type of cancer originating from the urethra. The incidence is approximately 0.43 per 100,000 in the United states for men, and approximately 0.15 per 100,000 for women. Types of urethral cancer include transitional cell carcinoma, squamous cell carcinoma, and adenocarcinoma. It may be caused by an infection of human papillomavirus. Urethra cancer must be differentiated from bladder cancer, cervical cancer, bladder stones, urethral stones, cystitis, neurogenic bladder, and urethritis. Common risk factors in the development of urethral cancer are history of bladder cancer, urinary tract infections, and sexually transmitted diseases. Symptoms of urethral cancer include hematuria, urinary hesitancy, frequent urination, incontinence, swelling in the groin, and a lump or thickness in the perineum or penis. The prognosis varies with the depth of invasion, anatomical location, size, and stage of the tumor. The predominant therapy for urethral cancer is surgical resection. Adjunctive chemotherapy or radiation therapy may be required.

Classification

Urethral cancer may be classified according to cell types into 3 subtypes: transitional cell, squamous cell, and adenocarcinoma. It may also be classified into distal urethral cancer, proximal urethral cancer and urethral cancer associated with invasive bladder cancer.

Causes

Urethral cancer may be caused by an infection of human papillomavirus.

Differential diagnosis

Urethral cancer must be differentiated from bladder cancer, cervical cancer, bladder stones, ureteral stones, cystitis, neurogenic bladder, and urethritis.

Epidemiology and Demographics

Urethral cancer is a rare disease that tends to affect African American individuals. The incidence is approximately 0.43 per 100,000 in the United states for men, and approximately 0.15 per 100,000 for women.

Risk Factors

Common risk factors in the development of urethral cancer are history of bladder cancer, urinary tract infections, and sexually transmitted diseases.

Prognosis

The prognosis varies with the depth of invasion, anatomical location, size, and stage of the tumor. Superficial tumors located in the distal urethra have the most favorable prognosis.

Diagnosis

Staging

The staging of urethral cancer is based on the TNM staging system.

Diagnostic study of choice

There is no single diagnostic study of choice for diagnosing urethral cancer. Cystourethroscopy is useful to evaluate the extent of the diseaseDefinitive diagnosis is made with transurethral biopsies.

History and Symptoms

Symptoms of urethral cancer include hematuria, urinary hesitancy, frequent urination, incontinence, swelling in the groin, and a lump or thickness in the perineum or penis.

Physical Examination

Common physical examination findings of urethral cancer include hematuria, urethral discharge, perineal/perigenital edema or mass.

Laboratory Findings

Laboratory findings consistent with the diagnosis of urethral cancer include abnormal cells in urine cytology and hematuria.

Electrocardiogram

There are no electrocardiogram findings associated with urethral cancer.

X-ray

There are no x-ray findings associated with urethral cancer.

Ultrasound

There are no echocardiography/ultrasound findings associated with urethral cancer.

CT scan

Abdomen and pelvis CT scan may be helpful in the diagnosis of urethral cancerFindings on CT scan include extravesical extension to lymph nodes, the liver or other structures around the bladder, nodal involvement in the pelvisor retroperitoneumvisceralpulmonary, or osseous metastasis.

MRI

Abdominal and pelvic MRI may be helpful in the diagnosis of urethral cancerMRI may be superior to CT scan to detect superficial and multiple tumors, extraurethral tumor extension, and surrounding organ invasion.

Other Imaging Findings

Cystoscopy may be helpful for initial diagnosis and staging of urethral cancer. Findings of cystoscopy include Multiple biopsy specimens from various locations and gross extravesical extension, invasion of adjacent organs, or pelvic sidewall involvement.

Other Diagnostic Studies

Other diagnostic studies for urethral cancer include ureteroscopy and biopsy.

Treatment

Medical Therapy

The predominant therapy for urethral cancer is surgical resection. Adjunctive chemotherapy or radiation therapy may be required. The optimal therapy depends on the stage at diagnosis and the anatomic location of the tumor.

Surgery

Surgery is the mainstay of treatment for urethral cancer. However, it is not recommended among patients with metastatic urethral cancer.

Primary prevention

There are no primary preventive measures available for urethral cancer.

Secondary prevention

There are no established measures for the secondary prevention of urethral cancer.